Health Care & Life Sciences » Biotechnology | ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
125.01 M
Public Float
78.76 M
ACADIA Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.1
Market Cap
$3.91 B
Shares Outstanding
144.17 M
Public Float
142.3 M

Profile

Address
3611 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.acadia-pharm.com
Updated 07/08/2019
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R.

Financials

View All

Stephen R. Biggar
Chairman
Stephen R. Davis
President, Chief Executive Officer & Director